Home
About
FAQ
History (2)
Principal Investigator
Risk factors and outcomes analyses at 36 months of a prospective, randomized, multicenter, trial of daclizumab induction in simultaneous kidney-pancreas transplant recipients.
See All 2 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Principal Investigator
Overview
researcher role of
Register, Thomas
contributes to
Atherosclerosis Stage, Estrogen Receptors, and Vascular Responses to Estrogen